Literature DB >> 12370812

Stabilization of p53 and transactivation of its target genes in response to replication blockade.

Bijaya K Nayak1, Gokul M Das.   

Abstract

Although it is clear that p53 plays a pivotal role in G1/G2 checkpoints to conserve genomic integrity, its role in S phase checkpoint is less well understood. Recently, it has been reported that p53 is transcriptionally impaired even though it is stabilized during replication blockade. However, the mechanisms underlying this phenomenon are not known. In the present study, it has been shown that p53 accumulates and transactivates its target genes such as p21, gadd45 and bax in response to replication blockade in normal and cancer cells. Lack of transcriptional activation under similar conditions in cells lacking p53 shows that p53-target gene activation during replication blockade is indeed p53-dependent. Further, transactivation of p21 in response to replication blockade by hydroxyurea and aphidicolin is similar to that in response to ionizing radiation except that the latter is more immediate compared to the response to replication blockade. These findings suggest that impairment of transcriptionally active p53 in response to replication blockade is not a general phenomenon.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370812     DOI: 10.1038/sj.onc.1205889

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  p53 mediates senescence-like arrest induced by chronic replicational stress.

Authors:  Andriy Marusyk; Linda J Wheeler; Christopher K Mathews; James DeGregori
Journal:  Mol Cell Biol       Date:  2007-05-21       Impact factor: 4.272

2.  Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites.

Authors:  B Joshi; S Rastogi; M Morris; L M Carastro; C DeCook; E Seto; S P Chellappan
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

3.  A reduction of licensed origins reveals strain-specific replication dynamics in mice.

Authors:  Tsuyoshi Kawabata; Satoru Yamaguchi; Tavanna Buske; Spencer W Luebben; Marsha Wallace; Ilze Matise; John C Schimenti; Naoko Shima
Journal:  Mamm Genome       Date:  2011-05-25       Impact factor: 2.957

4.  Drosophila dCBP is involved in establishing the DNA replication checkpoint.

Authors:  Sarah Smolik; Kristen Jones
Journal:  Mol Cell Biol       Date:  2006-10-16       Impact factor: 4.272

5.  The Roles of P53 and Its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis-Stage Mouse Embryos.

Authors:  Nazem El Husseini; Barbara F Hales
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

6.  Domain organization of the yeast histone chaperone FACT: the conserved N-terminal domain of FACT subunit Spt16 mediates recovery from replication stress.

Authors:  Allyson F O'Donnell; Neil K Brewster; Joelius Kurniawan; Laura V Minard; Gerald C Johnston; Richard A Singer
Journal:  Nucleic Acids Res       Date:  2004-11-01       Impact factor: 16.971

7.  p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled.

Authors:  Melissa Mattia; Vanesa Gottifredi; Kristine McKinney; Carol Prives
Journal:  Mol Cell Biol       Date:  2006-12-11       Impact factor: 4.272

8.  Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle.

Authors:  Martin Zydek; Christian Hagemeier; Lüder Wiebusch
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

9.  Relationship between VEGF and p53 expression and tumor cell proliferation in human gastrointestinal carcinomas.

Authors:  Elvira Montero; Carmen Abreu; Paola Tonino
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-17       Impact factor: 4.553

10.  Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cells.

Authors:  Yoko Itahana; Jinqiu Zhang; Jonathan Göke; Leah A Vardy; Rachel Han; Kozue Iwamoto; Engin Cukuroglu; Paul Robson; Mahmoud A Pouladi; Alan Colman; Koji Itahana
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.